Helen of Troy Limited (HELE) Guidance & Earnings Results

On 2026-10-08 Helen of Troy Limited raised guidance: "FY27 net sales narrowed to $1.768-$1.822B; GAAP EPS raised to $3.63-$4.26; adjusted EPS raised to $3.60-$4.15; GAAP net income raised to $88-$103M; operating cash flow raised to $163-$179M; adjusted EBITDA raised to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason

HELEHelen of Troy LimitedFollow HELE — free

Household & Personal Products · Consumer Defensive

—

Price chart with a free account

Market cap: 656.6M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 7 Jan, in 75 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
8 Oct 26	Raised	FY27 net sales narrowed to $1.768-$1.822B; GAAP EPS raised to $3.63-$4.26; adjusted EPS raised to $3.60-$4.15; GAAP net income raised to $88-$103M; operating cash flow raised to $163-$179M; adjusted EBITDA raised to $203-$210M; free cash flow raised to $120-$140M. · full year
8 Jul 26	Raised	FY2027 consolidated net sales raised to $1.759-1.831B; GAAP diluted EPS maintained $3.57-4.18; adjusted diluted EPS maintained $3.25-3.75; adjusted EBITDA maintained $190-197M; free cash flow maintained $85-100M · full year
9 Oct 25	Lowered	FY2026 net sales $1.739-$1.780B; adjusted EPS $3.75-$4.25 · full year

Helen of Troy Limited — questions

What guidance did Helen of Troy Limited give?: On 2026-10-08: "FY27 net sales narrowed to $1.768-$1.822B; GAAP EPS raised to $3.63-$4.26; adjusted EPS raised to $3.60-$4.15; GAAP net income raised to $88-$103M; operating cash flow raised to $163-$179M; adjusted EBITDA raised to $203-$210M; free cash flow raised to $120-$140M."
When does Helen of Troy Limited report earnings?: Helen of Troy Limited's next earnings report is expected on 2027-01-07.

Every figure on this page comes from Helen of Troy Limited's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.